journal article·2019-12-04Open access

Knockdown of lncRNA Gm11974 protect against cerebral ischemic reperfusion through miR-766-3p/NR3C2 axis

Jiangping Cai, Shina Shangguan, Guoqian Li, Yazhen Cai, Yuanjie Chen, Gaoting Ma, Zhongrong Miao, Lian Liu, Yiming Deng

Abstract

Aims: In previous studies, numerous differential lncRNAs in cerebral ischemic reperfusion injury were identified using RNA-Seq analysis. However, little is known about whether and how lncRNAs involved in cerebral I/R injury. In this study, we investigated the function and explored the possible mechanism of lncRNA Gm11974 in cerebral I/R injury.Methods: Oxygen glucose deprivation model in N2a cells were utilized to mimic the cerebral I/R injury in vitro. Trypan blue staining, Tunel, JC-1 and cell viability were measured to evaluate the function of lncRNA Gm11974. Dual-luciferase reporter assay was used to explore the potential mechanism of lncRNA Gm11974.Results: Gm11974 was mainly located in cytoplasm. Knockdown of lncRNA Gm11974 alleviated the apoptosis induced by OGD and cell death rates were significantly reduced. We further provided the possible mechanism that Gm11974/miR-766-3p/NR3C2 axis plays important role in cerebral I/R injury.Conclusions: We evaluated the function and mechanism of lncRNA Gm11974 in ischemic brain injury. LncRNA Gm11974 may serve as a potential target for new therapeutic intervention.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer-related molecular mechanisms research · Neurological Disease Mechanisms and Treatments · Traditional Chinese Medicine Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurology, The First Hospital of Quanzhou Affiliated to Fujian Medical University

Department of Neurology, Shandong University/Affiliated Hospital of Shandong Medical College

Departments of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University

China National Clinical Research Center for Neurological Diseases

Center of Stroke, Beijing Institute for Brain Disorders

Funding

Beijing Municipal Administration of Hospitals’Youth Program · Natural Science Foundation of Beijing · Medical Elite Cultivation Program of Fujian

References (25)

Show source-provided references
1. 10.1001/jama.2015.305810.1001/jama.2015.3058 ↗
2. 10.1056/NEJMoa141479210.1056/NEJMoa1414792 ↗
3. 10.1056/NEJMoa150378010.1056/NEJMoa1503780 ↗
4. 10.1007/s00401-018-1859-210.1007/s00401-018-1859-2 ↗
5. 10.1016/j.pneurobio.2017.10.00110.1016/j.pneurobio.2017.10.001 ↗
6. 10.1371/journal.pmed.100231010.1371/journal.pmed.1002310 ↗
7. 10.1038/srep3322910.1038/srep33229 ↗
8. 10.1111/cpr.1251510.1111/cpr.12515 ↗
9. 10.1038/nrneurol.2013.6710.1038/nrneurol.2013.67 ↗
10. 10.18632/oncotarget.974110.18632/oncotarget.9741 ↗
11. 10.1080/15384101.2018.156020210.1080/15384101.2018.1560202 ↗
12. 10.1016/j.bbrc.2019.04.16110.1016/j.bbrc.2019.04.161 ↗
13. 10.1016/j.expneurol10.1016/j.expneurol ↗
14. Zhong Y, Yu C, Qin W. LncRNA SNHG14 promotes inflammatory response induced by cerebral ischemia/reperfusion injury through regulating miR-136-5p/ROCK1 [J]. Cancer Gene Therapy. 2019. Jul;26(7-8):234–247.
15. 10.1172/JCI4627910.1172/JCI46279 ↗
16. 10.1016/j.expneurol.2015.12.01410.1016/j.expneurol.2015.12.014 ↗
17. 10.1016/j.cell.2009.02.00610.1016/j.cell.2009.02.006 ↗
18. 10.1161/CIRCULATIONAHA.115.02101910.1161/CIRCULATIONAHA.115.021019 ↗
19. 10.1007/s40199-018-0231-310.1007/s40199-018-0231-3 ↗
20. Li J, Wang J, Chen Y, et al. LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204 [J]. Am J Cancer Res. 2015;6(5):1099.
21. 10.1093/nar/gkz16810.1093/nar/gkz168 ↗
22. 10.1038/s41419-019-1566-510.1038/s41419-019-1566-5 ↗
23. 10.1038/ncomms1173010.1038/ncomms11730 ↗
24. Ding X, Jia X, Wang C, et al. A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer [J]. Cell Death Differ. 2019 Sep;26(9):1750–1765
25. 10.1038/s41388-018-0250-z10.1038/s41388-018-0250-z ↗